TY  - CONF

T1  - A phase II, randomized, open-label, pilot study to evaluate the safety and the effects on bone resorption of saracatinib (AZD0530) in patients with prostate cancer or breast cancer with metastatic bone disease

JO  - BONE

PY  - 2011/01/01

AU  - Aklilu M

AU  - Hussain A

AU  - Evans CP

AU  - Hannon RA

AU  - Lipton A

AU  - Dimairo M

AU  - Yu J

AU  - Zobel P

AU  - Torti FM

AU  - Finkelman RD

ED  - 

DO  - DOI: 10.1016/j.bone.2010.10.044

VL  - 48

IS  - 1

SP  - S17

EP  - S17

Y2  - 2024/12/22

ER  -